Stockscreener 앱 받기
15.44
4.36%
0.645
전일 마감가:
$14.79
열려 있는:
$14.87
하루 거래량:
152.70K
Relative Volume:
0.72
시가총액:
$578.05M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.42%
1개월 성능:
+9.78%
6개월 성능:
+40.06%
1년 성능:
+0.00%
1일 변동 폭
$14.68
$15.81
1주일 범위
$14.08
$15.81
52주 변동 폭
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
명칭
Oruka Therapeutics Inc
전화
650-606-7910
주소
855 OAK GROVE AVE., MENLO PARK
ORKA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
15.44 | 571.12M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-22 | 개시 | BTIG Research | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-10-11 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | H.C. Wainwright | Buy |
| 2024-09-17 | 개시 | Leerink Partners | Outperform |
| 2024-09-16 | 개시 | TD Cowen | Buy |
| 2024-09-13 | 개시 | Jefferies | Buy |
| 2018-02-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2013-10-09 | 개시 | Dawson James | Buy |
모두보기
Oruka Therapeutics Inc 주식(ORKA)의 최신 뉴스
Clear Street initiates Oruka Therapeutics stock with Buy rating on psoriasis drugs - Investing.com
Technical analysis overview for Oruka Therapeutics Inc. stockOil Prices & High Yield Stock Recommendations - Newser
What to expect from Oruka Therapeutics Inc. in the next 30 daysMarket Trend Summary & Reliable Entry Point Trade Alerts - Newser
Support Zone Holds Steady for Oruka Therapeutics Inc. After DipGold Moves & Momentum Based Trading Ideas - beatles.ru
How to integrate Oruka Therapeutics Inc. into portfolio analysis toolsIndex Update & Fast Momentum Entry Tips - Newser
Oruka Therapeutics Inc.’s volatility index tracking explainedMarket Performance Recap & Fast Exit and Entry Strategy Plans - Newser
Will Oruka Therapeutics Inc. outperform the marketAnalyst Upgrade & Community Supported Trade Ideas - Newser
Oruka Therapeutics Inc. stock trendline breakdown2025 Price Targets & Free Long-Term Investment Growth Plans - Newser
Applying Wyckoff theory to Oruka Therapeutics Inc. stockJuly 2025 Retail & Safe Capital Investment Plans - Newser
Real time scanner hits for Oruka Therapeutics Inc. explained2025 Sector Review & Fast Moving Stock Watchlists - Newser
Applying Elliott Wave Theory to Oruka Therapeutics Inc.2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Statistical indicators supporting Oruka Therapeutics Inc.’s strengthJuly 2025 Technicals & Technical Pattern Alert System - Newser
Oruka Therapeutics Inc. Attempts Reversal From Key SupportJuly 2025 Price Swings & Weekly Top Gainers Alerts - beatles.ru
Oruka Therapeutics (NASDAQ:ORKA) Given “Buy” Rating at HC Wainwright - Defense World
Applying sector rotation models to Oruka Therapeutics Inc.Quarterly Market Summary & Expert Approved Momentum Ideas - Newser
Smart tools for monitoring Oruka Therapeutics Inc.’s price actionGap Down & Low Drawdown Momentum Ideas - Newser
Is Oruka Therapeutics Inc. a candidate for recovery play2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser
Has Oruka Therapeutics Inc. found a price floorJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - Newser
Long term hold vs stop loss in Oruka Therapeutics Inc.Global Markets & Stepwise Trade Execution Plans - Newser
How high can Oruka Therapeutics Inc. stock price go in 2025Weekly Gains Report & Community Verified Trade Alerts - Newser
What Fibonacci levels say about Oruka Therapeutics Inc. reboundPortfolio Update Summary & Free Risk Controlled Daily Trade Plans - Newser
How to build a custom watchlist for Oruka Therapeutics Inc.2025 Bull vs Bear & Stock Timing and Entry Methods - Newser
What makes Oruka Therapeutics Inc. stock price move sharplyBear Alert & Daily Market Momentum Tracking - Newser
Oruka Therapeutics (NASDAQ:ORKA) Downgraded by Wall Street Zen to “Sell” - Defense World
Q3 EPS Estimates for Oruka Therapeutics Decreased by Wedbush - Defense World
Can technical indicators confirm Oruka Therapeutics Inc.’s reversalQuarterly Market Summary & Consistent Growth Stock Picks - Newser
Why Oruka Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Report & Consistent Income Trade Ideas - Newser
Oruka Therapeutics (NASDAQ:ORKA) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
What is the Moat Score of Oruka Therapeutics Inc.Quarterly Performance Summary & Fast Momentum Stock Entry Tips - thegnnews.com
Leerink Partnrs Has Pessimistic View of ORKA Q3 Earnings - Defense World
Custom watchlist performance reports with Oruka Therapeutics Inc.Earnings Growth Report & Community Trade Idea Sharing - Newser
Published on: 2025-08-13 20:29:16 - beatles.ru
Oruka Therapeutics’ (ORKA) Outperform Rating Reaffirmed at Wedbush - Defense World
Oruka Therapeutics stock maintains Buy rating at BTIG on promising psoriasis treatments - Investing.com Canada
Oruka Therapeutics Inc (ORKA) 재무 분석
Oruka Therapeutics Inc (ORKA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Oruka Therapeutics Inc 주식 (ORKA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Par | 10% Owner |
Feb 13 '25 |
Buy |
11.63 |
14,950 |
173,868 |
4,059,634 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 12 '25 |
Buy |
11.86 |
8,971 |
106,396 |
4,044,684 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 11 '25 |
Buy |
10.95 |
9,593 |
105,043 |
4,035,713 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 10 '25 |
Buy |
10.90 |
574 |
6,257 |
4,026,120 |
0.94%
1.72%
자본화:
|
볼륨(24시간):